MedPath

Aromatherapy Treatment With Lavender Essential Oil to Reduce Post-Operative Nausea and Vomiting (PONV)

Not Applicable
Active, not recruiting
Conditions
PONV
Registration Number
NCT07176676
Lead Sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Brief Summary

The aim of this study is to evaluate the effectiveness of aromatherapy through the use of inhaled Lavender oil in reducing patients' nausea during the post-operative period.

Detailed Description

To evaluate the effectiveness of inhaling Lavender Angustifolia essential oil in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative period.

Secondary objective

* To detect the number of antiemetic administrations in the experimental arm compared to the control arm

* To measure the patient satisfaction of patients in the experimental group with the Lavender essential oil aromatherapy intervention at hospital discharge Primary endpoint Reduction of nausea by at least 10% compared to treatment with standard care, as assessed by the NRS (Numerical Rating Scale).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Patients who sign an informed consent

    • Patients who have undergone anesthesiological examination
    • Patients undergoing general anaesthesia
    • Clinically stable patients
    • Patients with nausea scores detected with NRS>0
    • Patients admitted undergoing surgery in the Complex and/or Simple Structures listed below:
    • SC of Neurosurgery, undergoing spinal surgery
    • SC of General Surgery, undergoing surgery on one of the organs of the abdominal cavity
    • SC of Vascular Surgery, undergoing traditional surgical repair or endovascular procedure of abdominal aortic aneurysm. Sclerotherapy (to heal varicose veins) venous stripping (removal of a vein segment in the treatment of varicose veins) laser treatment
    • SS of Gynaecological Surgery, undergoing operations on the organs of the female genital apparatus.
Exclusion Criteria

Patients with ongoing relevant cognitive impairment (Six Item Screener score <4)

  • Patients with allergies or sensitivities to lavender essential oils
  • Patients with asthma, COPD, Chronic Bronchitis, Obstructive Sleep Apnea
  • Patients with changes in sense of smell

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
To evaluate the effectiveness of administering Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative periodduring the 24-hour post-operative period

To reduce nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative period.

Endpoint Reduction of nausea by at least 10% compared to treatment with standard care, as assessed by the NRS (Numerical Rating Scale).

Secondary Outcome Measures
NameTimeMethod
To evaluate the effectiveness of administering Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative periodduring the 24-hour postoperative period

To measure the number of antiemetic administrations in the experimental arm compared to the control arm

o evaluate the effectiveness of administering Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative periodduring the 24-hour postoperative period

To measure the patient satisfaction of the patients in the experimental group regarding the aromatherapy intervention with Lavender essential oil at hospital discharge

Trial Locations

Locations (1)

Clinical Trial Center

🇮🇹

Alessandria, Italy, Italy

Clinical Trial Center
🇮🇹Alessandria, Italy, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.